Knowles Corporation (KN) - Q2 2024 10-Q Summary
Business Context and Reporting Period
This report covers the quarterly period ended June 30, 2024. Knowles Corporation is a global provider of high-performance electronics, including capacitors, RF products, and audio solutions, serving medtech, defense, EV, industrial, and consumer electronics markets. The company operates through three segments: Precision Devices (PD), MedTech & Specialty Audio (MSA), and Consumer MEMS Microphones (CMM).
Key Financial Metrics (Three Months Ended June 30, 2024)
| Metric | Q2 2024 | Q2 2023 |
|---|---|---|
| Revenues | $204.7 million | $173.0 million |
| Gross Profit | $77.6 million (37.9% margin) | $73.7 million (42.6% margin) |
| Operating Loss | $(235.6) million | $16.9 million |
| Net Loss | $(259.3) million | $13.6 million |
| Diluted EPS | $(2.90) | $0.15 |
| Cash and Equivalents | $84.0 million | $54.4 million (Q2 2023) |
| Total Debt | $261.2 million | $271.2 million (Dec 31, 2023) |
| Operating Cash Flow (6mo) | $42.2 million | $22.4 million |
Material Changes vs. Prior Period
- Revenue Growth: Revenues increased 18.3% year-over-year to $204.7 million, driven by the acquisition of Cornell Dubilier (CD) and higher demand in mobile and medtech markets.
- Goodwill Impairment: The company recorded a non-cash goodwill impairment charge of $249.4 million in the CMM segment. This resulted from a strategic review determining the fair value of the CMM reporting unit was below its carrying value.
- Profitability Decline: GAAP net loss widened significantly to $259.3 million from a profit of $13.6 million in Q2 2023, primarily due to the impairment charge and higher operating expenses.
- Non-GAAP Performance: Excluding the impairment and other items, Non-GAAP net earnings were $22.5 million ($0.24 per share), compared to $21.9 million ($0.23 per share) in Q2 2023.
- Segment Results:
- Precision Devices: Revenue up 55.0% to $74.1 million due to CD acquisition.
- MedTech & Specialty Audio: Revenue flat at $59.5 million; EBIT margin improved to 40.3%.
- Consumer MEMS Microphones: Revenue up 10.1% to $71.1 million, but reported a loss of $246.4 million due to the impairment charge.
Guidance, Outlook, and Risks
- Strategic Review: The company continues to review strategic alternatives for the CMM business, including a potential sale or restructuring. No timetable for conclusion has been set.
- Liquidity: The company maintains a $400 million revolving credit facility with $146.0 million outstanding as of June 30, 2024. It expects to reduce cash balances in the second half of the year to pay down the Seller Note related to the CD acquisition.
- Capital Allocation: The company repurchased $25.0 million of common stock in the first six months of 2024. Approximately $72.7 million remains available under the current repurchase program.
- Risks: Key risks include the potential for additional impairment charges, weakening demand for MEMS microphones, price erosion in mature products, and the ability to realize synergies from the CD acquisition.
Investor Verification Checklist
- Impairment Details: Verify the assumptions used in the fair value calculation for the CMM segment that led to the $249.4 million impairment.
- Strategic Alternatives: Monitor updates on the potential sale or restructuring of the CMM business and any impact on future cash flows.
- CD Integration: Assess the integration progress of the Cornell Dubilier acquisition and its contribution to the Precision Devices segment margins.
- Debt Covenants: Confirm continued compliance with debt covenants, specifically the Interest Coverage Ratio and Total Net Leverage Ratio, given the recent earnings volatility.
- Non-GAAP Reconciliation: Review the reconciliation of GAAP to Non-GAAP measures to understand the core operating performance excluding the impairment and restructuring costs.